← Back
Data updated: Mar 10, 2026
NORDIC PHARMA
MetabolicImmunology
NORDIC PHARMA is a pharmaceutical company focused on Metabolic, Immunology.
1984
Since
1
Drugs
-
Trials
0
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
No recent activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Metabolic 60%
1 drugs
Immunology 40%
0 drugs Phase 3: 1
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 1984-03-30
- Latest
- 2022-07-21
- Applications
- 1